Abstract: The present invention is related to treated filler and processes for producing said treated filler. Untreated filler slurry can be treated with a treating material and, optionally, a coupling material and then subjected to conventional drying method(s), to produce the treated filler of the invention. Treated filler has a wide variety of applications including but not limited to battery separators and rubber compositions such as tires.

Abstract: Provided is a microporous material including (a) a polyolefin matrix which is 30 to 80 weight percent high density polyolefin, (b) finely divided particulate filler distributed throughout the matrix including 10 to 30 weight percent or less of calcium carbonate, and (c) at least 35 percent by volume of a network of interconnecting pores communicating throughout the microporous material. The microporous material has a density ranging from 0.5 to 0.8 g/cc, a Sheffield smoothness of less than or equal to 40, a air flow rate of 1000 or more Gurley seconds, and MD stress at 1% strain of greater than or equal to 200 psi. Printed electronic devices prepared from the microporous material also are provided.

Abstract: An improved process for bisphosphonylation of acids, substituted acids to obtain compounds with the formula using phosphorus trihalide, phosphorus acid, in presence of phenolic compounds as diluent/solvent.

Abstract: Provided is a multi-layer article including (1) a sheet of microporous material having opposing surfaces, and (2) an adhesive composition applied over at least a portion of at least one of the surfaces of the sheet. The microporous material contains (A) a polymeric matrix component of 5 to 100 weight percent of low melt flow index polypropylene; 0 to 90 weight percent of ultrahigh molecular weight polyethylene; and 0 to 90 weight percent of high density polyethylene; (B) a finely divided, particulate filler component dispersed throughout the polymeric matrix (A) including siliceous and non-siliceous materials; and (C) a network of interconnecting pores communicating substantially throughout the microporous material, the pores constituting 10 to 80 percent by volume of the microporous material, wherein the weight ratio of filler component (B) to polymeric matrix component (A) ranges from 0.1 to 10.0.

Abstract: Provided is a microporous material, e.g., a microporous sheet material, having a matrix of polyolefin, finely-divided, substantially water insoluble particulate filler, a network of interconnecting pores communicating throughout the microporous material, and at least one retrospectively identifiable taggant material embedded within the matrix, wherein the polyolefin is present in the microporous material in an amount of 20 to 60 weight percent, based on the weight of the microporous material. The taggant material provides a marker, signature or code that is capable of retrospective identification by machine, instrument or by the naked eye. Articles including the microporous material and processes for preparing the microporous material also are provided.

Abstract: Described are microporous materials including (a) a polymeric matrix component; (b) a finely divided, particulate inorganic filler component dispersed throughout the polymeric matrix; and (c) a network of interconnecting pores communicating substantially throughout the microporous material, the pores constituting 10 to 80 percent by volume of the microporous material. The polymeric component is based on (i) 5 to 100 weight percent based on total weight of component (a) of low melt flow index polypropylene; (ii) 0 to 90 weight percent based on total weight of component (a) of ultrahigh molecular weight polyethylene; and (iii) 0 to 90 weight percent based on total weight of component (a) of high density polyethylene. Also provided are multi-layer articles prepared from the microporous materials.

Abstract: An improved process for bisphosphonylation of acids, substituted acids to obtain compounds with the formula using phosphorus trihalide, phosphorus acid, in presence of phenolic compounds as diluent/solvent.

Abstract: The present invention is directed to an attrition resistant carrier product such as silica. Further, this invention is directed to the use of a binder to improve the attrition resistance or reduce the friability of a carrier product such as silica. In an embodiment, the median particle size is from 125 to 300 microns. Selection of the binder is such that the presence and/or addition of the binder does not result in substantial modification of the physical properties of the silica. Suitable binders include Group I and Group II silicates, Group I and Group II aluminates, and mixtures thereof, as identified by the Period Table of Elements.

Abstract: The present invention provides a chewing gum composition containing an active ingredient. The preferred chewing gum composition comprises a plurality of granules comprising a mixture of a powdered chewing gum base and a selected amount of a powdered active ingredient, said powdered chewing gum base and powdered active ingredient being mixed together within said granules. Additives may be mixed in the granules or may coat the granules. The preferred form is a tablet containing a controlled dosage form of the active ingredient.

Abstract: Topical oral dosage forms containing bismuth compounds are described, which are useful for treating H. pylori and other bacterial infections that cause gastrointestinal disorders and halitosis, as well as for treating ocular and dermal wounds. Methods of employing topical oral dosage forms for treating bacterial infections that cause gastrointestinal disorders and halitosis, and for treating ocular and dermal wounds, are also described.

Abstract: The present invention provides a chewing gum composition containing an active ingredient. The preferred chewing gum composition comprises a plurality of granules comprising a mixture of a powdered chewing gum base and a selected amount of a powdered active ingredient, said powdered chewing gum base and powdered active ingredient being mixed together within said granules. Additives may be mixed in the granules or may coat the granules. The preferred form is a tablet containing a controlled dosage form of the active ingredient.

Abstract: The present invention is directed to an attrition resistant carrier product such as silica. Further, this invention is directed to the use of a binder to improve the attrition resistance or reduce the friability of a carrier product such as silica. In an embodiment, the median particle size is from 125 to 300 microns. Selection of the binder is such that the presence and/or addition of the binder does not result in substantial modification of the physical properties of the silica. Suitable binders include Group I and Group II silicates, Group I and Group II aluminates, and mixtures thereof, as identified by the Period Table of Elements.

Abstract: The invention provides a method of making a chewing gum composition containing a water soluble bulk portion, a water insoluble chewing gum base portion, a flavoring agent, and bismuth-containing compounds. The invention provides a method of making a bismuth-containing gum which when chewed multiple times per day, over the period of two weeks, is effective in reducing peptic ulcers by eradicating H. pylori. The chewing gum is also effective in eliminating forms of halitosis. The chewing gum does not have undesirable side effects, such as unpleasant taste and poor chewing characteristics.

Abstract: Topical oral dosage forms containing bismuth compounds are described, which are useful for treating H. pylori and other bacterial infections that cause gastrointestinal disorders and halitosis, as well as for treating ocular and dermal wounds. Methods of employing topical oral dosage forms for treating bacterial infections that cause gastrointestinal disorders and halitosis, and for treating ocular and dermal wounds, are also described.

Abstract: This invention provides for a method for treatment of corneal and dermal wounds by administering bismuth compounds in topical dosage forms. Bismuth compounds cause stimulation of release of growth factors in damaged tissue to promote regeneration of epithelial cells and hence accelerate wound healing. These bismuth compounds also have good antimicrobial activity against several anaerobic bacteria involved in diaper rash exacerbation.

Abstract: This invention provides for a method for treatment of corneal and dermal wounds by administering bismuth compounds in topical dosage forms. Bismuth compounds cause stimulation of release of growth factors in damaged tissue to promote regeneration of epithelial cells and hence accelerate wound healing. These bismuth compounds also have good antimicrobial activity against several anaerobic bacteria involved in diaper rash exacerbation.

Abstract: The present invention provides a process for preparing a chewing gum tablet, in which a chewing gum composition is cooled to a temperature at which the composition is brittle, and the composition is ground while brittle to form a fine powder. In a preferred process, the composition is cooled by mixing with a coolant, such as solid carbon dioxide, and the mixture is ground to a powder. The powder can be mixed with a pharmaceutical active ingredient capable of topical absorption in the buccal cavity or in the mucous layer of the upper or lower intestinal tract, and formed into a tablet. Preferably, the mixture of the powder, pharmaceutical active ingredient, and other additives such as coating agents, binders, additional active ingredients, and sweeteners, are granulated in a fluidized bed granulator prior to forming the mixture into a tablet. The resulting tablet provides a dosage form of the pharmaceutical active ingredient having a more accurate and uniform dose of the active ingredient.

Abstract: The invention provides a chewing gum composition containing a water soluble bulk portion, a water insoluble chewing gum base portion, a flavoring agent, and bismuth-containing compounds. The invention provides a bismuth-containing gum which when chewed multiple times per day, over the period of two weeks, is effective in reducing peptic ulcers by eradicating H. pylori. The chewing gum is also effective in eliminating forms of halitosis. The chewing gum does not have undesirable side effects, unpleasant taste and poor chewing characteristics.

Abstract: The invention provides a method of making a chewing gum composition containing a water soluble bulk portion, a water insoluble chewing gum base portion, a flavoring agent, and bismuth-containing compounds. The invention provides a method of making a bismuth-containing gum which when chewed multiple times per day, over the period of two weeks, is effective in reducing peptic ulcers by eradicating H. pylori. The chewing gum is also effective in eliminating forms of halitosis. The chewing gum does not have undesirable side effects, unpleasant taste and poor chewing characteristics.

Abstract: A process for producing a molecular sieve silica membrane comprising depositing a hybrid organic-inorganic polymer comprising at least one organic constituent and at least one inorganic constituent on a porous substrate material and removing at least a portion of the at least one organic constituent of the hybrid organic-inorganic polymer, forming a porous film.